Counselors in Paige, TX Accepting Medicare
3 Counselors found. Showing 1 - 3
 Charity Rogers, LPC, LCDC Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 153 Ridgeway Cemetery Road, Paige, TX 78659 Phone: 512-660-7976 |
Ms. Casey Unger, LPC Counselor - Professional Medicare: Not Enrolled in Medicare Practice Location: 197 Tonkawa Dr, Paige, TX 78659 Phone: 979-255-4176 |
 John R Freeman, LCDC, CADC Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 110 Apache Dr, Paige, TX 78659 Phone: 512-284-0376 |
News Archive
Pfizer and Medivation drop further testing of failed Alzheimer's drug
A phase III clinical trial of an investigational Alzheimer's disease drug dimebon failed to show encouraging results dooming its future according to its commercial sponsors.
Scientists create new method of particle tracking based on machine learning
Scientists at the University of North Carolina at Chapel Hill have created a new method of particle tracking based on machine learning that is far more accurate and provides better automation than techniques currently in use.
Decker Foundation gift helps Binghamton University to establish lab for improving health outcomes
A gift from the Dr. G. Clifford & Florence B. Decker Foundation will enable Binghamton University biologists and their colleagues to conduct tests and research that will improve health outcomes for patients in Southern Tier hospitals with conditions ranging from ear infections to cancer.
Transplantation of pulmonary progenitor cells derived from hESCs promising for acute lung injury
Stem cell researchers exploring a new approach for the care of respiratory diseases report that an experimental treatment involving transplantable lung cells was associated with improved outcomes in tests on mice with acute lung injury. The lung cells were derived from human embryonic stem cells (hESCs). Findings by investigators at The University of Texas Health Science Center at Houston are scheduled to appear in the March issue of Molecular Therapy.
NASDAQ issues noncompliance letter to Sunesis Pharmaceuticals
Sunesis Pharmaceuticals, Inc. (Nasdaq: SNSS) reported today that it received a letter, dated September 16, 2009, from the Listing Qualifications Staff (the "Staff") of The NASDAQ Stock Market notifying Sunesis that it does not comply with the minimum $1.00 per share requirement for continued listing on The NASDAQ Capital Market set forth in NASDAQ Listing Rule 5550(a)(2).
› Verified 6 days ago